BIOMAT Database Logo BIOMAT Database Logo

Structures of rishirilides A and B, alpha 2-macroglobulin inhibitors produced by Streptomyces rishiriensis OFR-1056. 1984

H Iwaki, and Y Nakayama, and M Takahashi, and S Uetsuki, and M Kido, and Y Fukuyama

UI MeSH Term Description Entries
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D000511 alpha-Macroglobulins Glycoproteins with a molecular weight of approximately 620,000 to 680,000. Precipitation by electrophoresis is in the alpha region. They include alpha 1-macroglobulins and alpha 2-macroglobulins. These proteins exhibit trypsin-, chymotrypsin-, thrombin-, and plasmin-binding activity and function as hormonal transporters. Slow alpha 2-Macroglobulins,alpha 2-Acute Phase Globulins,alpha-Macrofetoproteins,45S RNP,Acute-Phase alpha 1-Protein,Slow alpha 2-Globulin,alpha 1-Acute Phase Globulin,alpha 1-Acute Phase Protein,alpha 1-Macroglobulin,alpha 2-Acute Phase Globulin,alpha-Macrofetoprotein,Acute Phase alpha 1 Protein,RNP, 45S,Slow alpha 2 Globulin,Slow alpha 2 Macroglobulins,alpha 1 Acute Phase Globulin,alpha 1 Acute Phase Protein,alpha 1 Macroglobulin,alpha 1-Protein, Acute-Phase,alpha 2 Acute Phase Globulin,alpha 2 Acute Phase Globulins,alpha 2-Globulin, Slow,alpha 2-Macroglobulins, Slow,alpha Macrofetoprotein,alpha Macrofetoproteins,alpha Macroglobulins
D000873 Anthracenes A group of compounds with three aromatic rings joined in linear arrangement.
D013302 Streptomyces A genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the ANTI-BACTERIAL AGENTS of practical value.
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical

Related Publications

H Iwaki, and Y Nakayama, and M Takahashi, and S Uetsuki, and M Kido, and Y Fukuyama
Lactonamycin, a new antimicrobial antibiotic produced by Streptomyces rishiriensis.
September 1996, The Journal of antibiotics,
H Iwaki, and Y Nakayama, and M Takahashi, and S Uetsuki, and M Kido, and Y Fukuyama
A possible mechanism of immunoregulation produced by alpha 2-macroglobulin.
January 1983, Annals of the New York Academy of Sciences,
H Iwaki, and Y Nakayama, and M Takahashi, and S Uetsuki, and M Kido, and Y Fukuyama
Lactonamycin, a new antimicrobial antibiotic produced by Streptomyces rishiriensis MJ773-88K4. II. Structure determination.
March 1999, The Journal of antibiotics,
H Iwaki, and Y Nakayama, and M Takahashi, and S Uetsuki, and M Kido, and Y Fukuyama
Plasminogen activators, activation inhibitors and alpha 2-macroglobulin produced by cultured normal and malignant human cells.
May 1984, International journal of cancer,
H Iwaki, and Y Nakayama, and M Takahashi, and S Uetsuki, and M Kido, and Y Fukuyama
2"-N-formimidoylistamycin A and B produced by Streptomyces tenjimariensis.
August 1982, The Journal of antibiotics,
H Iwaki, and Y Nakayama, and M Takahashi, and S Uetsuki, and M Kido, and Y Fukuyama
Phosphatoquinones A and B, novel tyrosine phosphatase inhibitors produced by Streptomyces sp.
February 1999, The Journal of antibiotics,
H Iwaki, and Y Nakayama, and M Takahashi, and S Uetsuki, and M Kido, and Y Fukuyama
New subtilisin-trypsin inhibitors produced by Streptomyces: primary structures and their relationship to other proteinase inhibitors from Streptomyces.
February 1996, Biochimica et biophysica acta,
H Iwaki, and Y Nakayama, and M Takahashi, and S Uetsuki, and M Kido, and Y Fukuyama
NK30424A and B, novel inhibitors of lipopolysaccharide-induced tumour necrosis factor alpha production, produced by Streptomyces sp. NA30424.
December 2001, The Journal of antibiotics,
H Iwaki, and Y Nakayama, and M Takahashi, and S Uetsuki, and M Kido, and Y Fukuyama
Protease inhibitors of human plasma. Alpha-2-macroglobulin.
January 1985, Journal of medicine,
H Iwaki, and Y Nakayama, and M Takahashi, and S Uetsuki, and M Kido, and Y Fukuyama
Migracins A and B, new inhibitors of cancer cell migration, produced by Streptomyces sp.
April 2013, The Journal of antibiotics,
Copied contents to your clipboard!